Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission
Ilaria S. Pagani(South Australian Health and Medical Research Institute), David M. Ross(South Australia Pathology), Randall Grose(South Australian Health and Medical Research Institute), Lisa Carne(Royal Adelaide Hospital), Deborah L. White(ANZCHOG), Haley Altamura(South Australia Pathology), Naranie Shanmuganathan(South Australia Pathology), Zandy Rwodzi(Royal Adelaide Hospital), Jodi Braley(South Australia Pathology), Timothy P. Hughes(South Australia Pathology), Jennifer McLean(South Australian Health and Medical Research Institute), Chung Hoow Kok(South Australian Health and Medical Research Institute), Sophie Watts(South Australian Health and Medical Research Institute), Verity A Saunders(South Australia Pathology), Agnes S. M. Yong(South Australia Pathology), David T Yeung(South Australia Pathology), Phuong Dang(South Australia Pathology), Susan Branford(Centre for Cancer Biology)
Cited by 51
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
|New England Journal of Medicine|2019|464